Events & Presentations

Events & Presentations

Upcoming Events
More events are coming soon.
Presentations
Date Documents
January 6, 2021
Prothena Corporate Overview: LifeSci Advisors 10th Annual Corporate Access Event
November 4, 2020
Poster: Development of a Dual Aβ/Tau Vaccine for the Prevention and Treatment of Alzheimer’s Disease
November 4, 2020
Poster: Novel Amyloid Beta Monoclonal Antibodies With Superior Binding Properties: Potential for More Convenient Dosing and Greater Patient Access in Alzheimer’s Disease
September 15, 2020
Poster: PASADENA: A Phase II study to evaluate the safety and efficacy of prasinezumab in early Parkinson's disease: Part I Week-52 results
September 15, 2020
Investor Presentation: Prasinezumab Slows Progression on Measures of Parkinson’s Disease in Phase 2 PASADENA Study
April 2, 2020
A Phase 2 study to evaluate the safety and efficacy of prasinezumab in early Parkinson's disease (PASADENA): rationale, design and baseline data
Archived Events
Date Event Details
Dec 9, 2020 8:30 AM EST
PRX004 Phase 1 Study Results
Listen to webcast
Nov 19, 2020 2:55 PM EST
Jefferies Virtual London Healthcare Conference
Listen to webcast
Nov 17, 2020 4:00 PM EST
Stifel 2020 Virtual Healthcare Conference
Listen to webcast
Sep 15, 2020 4:00 PM EDT
2020 Cantor Virtual Global Healthcare Conference
Listen to webcast
Sep 15, 2020 1:30 PM EDT
Phase 2 PASADENA Study Results
Listen to webcast
Aug 11, 2020 1:00 PM EDT
BTIG Biotechnology Conference 2020
Listen to webcast
Jun 3, 2020 3:30 PM EDT
Jefferies Virtual Healthcare Conference
Listen to webcast
Feb 12, 2020 4:30 PM EST
Prothena Fourth Quarter and Full Year 2019 Financial Results Conference Call
Listen to webcast